Evaluation of the Phased Radio Frequency Ablation System
NCT ID: NCT01693120
Last Updated: 2025-02-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
199 participants
INTERVENTIONAL
2013-11-30
2017-02-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection
NCT04076917
Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation
NCT06791629
Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
NCT00111488
Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation
NCT00224341
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF
NCT04198701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ablation
Phased RF ablation
Medtronic Phased RF Ablation System
Phased RF ablation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medtronic Phased RF Ablation System
Phased RF ablation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Failure of at least one anti-arrhythmic drug
Exclusion Criteria
* Prior ablation in left atrium for AF
* Known sensitivities (or allergy) to heparin, warfarin, contrast media
* Contraindicated for MRI
* Invasive cardiovascular procedure performed or planned within 3 month period of ablation procedure
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Ablation Solutions
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Hummel, MD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Phoenix Cardiovascular - Banner
Phoenix, Arizona, United States
Hoag Hospital
Newport Beach, California, United States
Medical Center of the Rockies
Fort Collins, Colorado, United States
Mayo Clinic
Jacksonville, Florida, United States
St. Vincent's Ambulatory Care
Jacksonville, Florida, United States
Tallahassee Research Institute
Tallahassee, Florida, United States
Piedmont Heart Institute
Atlanta, Georgia, United States
Emory University
Atlanta, Georgia, United States
Northeast Georgia Heart Center
Gainesville, Georgia, United States
Northwestern University
Chicago, Illinois, United States
Iowa Heart Center
Des Moines, Iowa, United States
University of Iowa
Iowa City, Iowa, United States
Baptist Health Lexington
Lexington, Kentucky, United States
University of Michigan
Ann Arbor, Michigan, United States
Spectrum Health Hospitals
Grand Rapids, Michigan, United States
DLP Marquette Physicians Practice
Marquette, Michigan, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
HealthEast St Joseph's Hospital
Saint Paul, Minnesota, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, United States
Asheville Cardiology
Asheville, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
The Ohio State University
Columbus, Ohio, United States
Doylestown Cardiology - VIAA
Doylestown, Pennsylvania, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania, United States
Baylor Research Institute - Dallas
Dallas, Texas, United States
St. Luke's Episcopal Hospital
Houston, Texas, United States
Baylor Research Institute - Plano
Plano, Texas, United States
University of Virginia Medical Center
Charlottesville, Virginia, United States
Inova Fairfax Hospital
Falls Church, Virginia, United States
Swedish Medical Center - Cherry Hill
Seattle, Washington, United States
Southlake Regional Health Centre
Newmarket, Ontario, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Hopital du Sacre Coeur de Montreal
Montreal, Quebec, Canada
Debreceni Egyetem
Debrecen, , Hungary
Catharina Ziekenhuis
Eindhoven, , Netherlands
St. Antonius Ziekenhuis
Nieuwegein, , Netherlands
Basildon and Thurrock University Hospitals
Basildon, , United Kingdom
Blackpool, Fylde and Wyre Hospitals
Blackpool, , United Kingdom
Newcastle Upon Tyne Hospitals
Newcastle upon Tyne, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VICTORY AF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.